Navigation Links
Cooling decreases heart attack effects

Reducing body temperature by just a few degrees minimises brain damage resulting from a cardiac arrest.When the heart suddenly stops - cardiac arrest - there's a great danger that the brain will be starved of oxygen. //Even if the person survives, they run the risk of permanent brain damage. It's been suggested that perhaps cooling the body can reduce the brain's demand for oxygen and this may protect it after a cardiac arrest.

Doctors in Vienna have been testing this idea. They looked at patients who had experienced cardiac arrest due to ventricular fibrillation - an abnormal heart rhythm. One group had their body temperature reduced to 34 to 32 degrees - hypothermia - over 24 hours, while the other group received normal care.

After six months, 50 per cent of the hypothermia group had had a good neurologic outcome, with minimal disability, compared to 20 per cent of controls. Mortality at six months was 30 per cent in the hypothermia group, compared to 10 per cent in the controls. But there was no difference between the two groups in the complication rate seven days following the arrest. The study shows that hypothermia may indeed be an effective treatment for cardiac arrest.


'"/>




Page: 1

Related medicine news :

1. Cooling treatment for newborn asphyxia
2. Stroke Patients May Benefit By Wearing Cooling Helmets
3. Cooling Can Reduce The Risk Of Brain Damage In Oxygen Deprived Newborns
4. Effect Of Cooling And Exercise To Be Analyzed In Patients With Multiple Sclerosis
5. Cooling Off As A Treatment Option For Heart And Trauma Patients
6. Survival After Cardiac Arrest Is Aided By Cooling
7. Current Cooling Devices Ineffective in Preventing Brain Injury
8. Existing Brain Cooling Not Beneficial To Trauma Patients
9. Cooling Towers may Cause Severe Respiratory Diseases
10. Cooling Temperatures Help Crucian Carp
11. Headache decreases appetite
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: